Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis. 2020

Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
From the Department of Medicine, First Chair of Internal Medicine (A.C., E.G., G.B., V.D.), University of Padua Medical School, Italy.

Aortic stenosis may be complicated by an acquired von Willebrand syndrome that rarely causes significant bleeding, raising the question of why it does so in a few cases. To seek an explanation, we studied 5 severe bleeder aortic stenosis patients in a cohort of 49 patients, using the flowchart for inherited von Willebrand disease. Approach and Results: All 5 patients were lacking in large and intermediate VWF (von Willebrand factor) multimers, 3 had reduced plasma and platelet VWF levels, and none showed PFA100 closure. Two patients (those with most multimers missing) also had a short VWF half-life. Genetic analyses on the 3 patients with reduced platelet VWF levels revealed that one carried both the c.1164C>G and the c.7880G>A mutations, and another carried the c.3390C>T mutation, while the third had one of the 2 VWF alleles relatively less expressed than the other (25% versus 75%). No genetic alterations emerged in the other 2 patients. Successful replacement of the stenotic aortic valve, performed in the 2 patients with VWF mutations, did not correct their abnormal VWF multimer picture-unlike what happened in the aortic stenosis patients without bleeding symptoms. Our findings suggest that acquired von Willebrand syndrome can develop in patients with hitherto-undiagnosed inherited von Willebrand disease. Since von Willebrand disease is the most common bleeding disorder, this possibility should be considered in aortic stenosis patients-especially those with a more severe bleeding history and more disrupted VWF laboratory patterns-because they risk hemorrhage during aortic valve replacement.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
January 2015, Journal of atherosclerosis and thrombosis,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
July 2003, The New England journal of medicine,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
March 2006, The Annals of thoracic surgery,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
January 2016, Cardiovascular journal of Africa,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
July 2003, The New England journal of medicine,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
October 2003, The New England journal of medicine,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
October 2003, The New England journal of medicine,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
October 2003, The New England journal of medicine,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
April 2015, JACC. Cardiovascular interventions,
Alessandra Casonato, and Eva Galletta, and Giuseppe Cella, and Giovanni Barbon, and Viviana Daidone
January 2015, Boletin de la Asociacion Medica de Puerto Rico,
Copied contents to your clipboard!